search
California State University
Trends
- 1California firm licenses anti-measles antibodies from Vanderbilt Health▼California firm licenses ‘potent’ anti-measles antibodies from Vanderbilt Health for development, clinical testing
A California biotech company has licensed potent anti-measles antibodies developed by Vanderbilt University Medical Center, with plans to develop them further and move them into clinical testing. The antibodies, discovered by Vanderbilt researchers, could offer a new tool against a disease resurging in the United States and globally amid declining vaccination rates.